En español
NIDA

Treatment Research

Office Meets Dynamic Challenges of Diversity

Describes NIDA’s Special Populations Office which promotes addiction science that examines health disparities and foster research careers among members of underrepresented communities.

Methylphenidate for Comorbid Cocaine Abuse, ADHD

Describes an inpatient study investigating the effectiveness of sustained-release methylphenidate as a treatment for cocaine-addiction patients with ADHD.

Medical Care During Addiction Treatment Reduces Hospital Use

Reports on an analysis comparing three types of addiction treatment programs: methadone maintenance programs, long-term residential programs, and nonmethadone programs.

Cocaine Abusers' Pretreatment Cue Responses Predict Recovery Success

Reports on the work of researchers who used brain images to correlate cocaine-addicted patients' regional brain responses to drug cues with their outcomes in subsequent treatment.

Journal Highlights Opportunities in Hispanic Drug Abuse Research

Reviews a journal supplement that compiles information on drug abuse research in the Hispanic population.

Videos Help Treat Deaf People

Reviews a training DVD that presents dialectical behavior therapy skills being taught by deaf clinicians to deaf consumers as an approach to improve deaf people's access to behavioral health care.

Standard Treatments Help Depressed Smokers Quit

Describes a study comparing Staged Care Intervention, a combination treatment for smoking cessation, among smokers in outpatient treatment for depression and a control group.

Serotonin System May Have Potential as a Target for Cocaine Medications

Describes investigations to advance the development of potential drug abuse relapse prevention agents by targeting specific receptors of the neurochemical serotonin.

Antipsychotic Drug Prevents Morphine Tolerance in Mice

Summarizes animal studies indicating that an antipsychotic drug, trifluoperazine, prevents morphine tolerance in mice.

Naltrexone-Nicotine Patch Combination Shows Promise

Reports findings from a clinical trial investigating the effectiveness of naltrexone as a supplement to nicotine replacement therapy for smoking cessation.

Pages

Subscribe to Treatment Research